Articles dans des revues avec comité de lecture (103)
1.
Jiang, C., Song, Y., Rorive, S., Allard, J., Tika, E., Zahedi, Z., Dubois, C., Salmon, I., Sifrim, A., & Blanpain, C. (2025). Innate immunity and the NF-κB pathway control prostate stem cell plasticity, reprogramming and tumor initiation. Nature Cancer, 6(9), 1537-1558. doi:10.1038/s43018-025-00994-32.
Blanc, J., Carnot, A., Barthélémy, P., Casert, V., Sautois, B., Van den Brande, J., Vanhaudenarde, V., Staudacher, L., Seront, E., Debien, V., Ameye, L., Kotecki, N., Rothé, F., Rorive, S., Fantoni, J. C., Tricard, T., Roumeguère, T., Awada, A., & Martinez Chanza, N. (2025). Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial. Journal for ImmunoTherapy of Cancer, 13(5). doi:10.1136/jitc-2025-0120453.
Verocq, C., Noël, J. C., Charry, M., Zindy, E., Rorive, S., Salmon, I., Decaestecker, C., & Catteau, X. (2024). Inverse correlation between the amounts of lymphocytic infiltrate and stroma in breast carcinoma. Heliyon, 10(22), e40295. doi:10.1016/j.heliyon.2024.e402955.
Gleeson, P. J., Crippa, I. A., Sannier, A., Koopmansch, C., Bienfait, L., Allard, J., Sexton, D. D., Fontana, V., Rorive, S., Vincent, J. L., Creteur, J., & Taccone, F. S. (2023). Critically ill patients with acute kidney injury: clinical determinants and post-mortem histology. Clinical Kidney Journal, 16(10), 1664-1673. doi:10.1093/ckj/sfad1136.
Belhaj, A., Dewachter, L., Monier, A., Vegh, G., Rorive, S., Remmelink, M., Closset, M., Melot, C., Creteur, J., Salmon, I., & Rondelet, B. (2023). Beneficial Effects of Tacrolimus on Brain-Death-Associated Right Ventricular Dysfunction in Pigs. International Journal of Molecular Sciences (CD-ROM), 24(13), 10439. doi:10.3390/ijms2413104397.
Rusu, S., Remmelink, M., Van Eycken, M., Pletschette, Z., Bennouna, I., Fouarge, A., Trepant, A.-L., Salmon, I., Rorive, S., & Lebrun, L. (2022). Monomicrobial Necrotizing Fasciitis and Emphysematous Cystitis: Autopsy Report and Literature Review. Annals of Case Reports.8.
Belhaj, A., Dewachter, L., Hupkens, E., Remmelink, M., Galanti, L., Rorive, S., Melot, C., Naeije, R., & Rondelet, B. (2022). Tacrolimus Prevents Mechanical and Humoral Alterations in Brain Death-induced Lung Injury in Pigs. American journal of respiratory and critical care medicine, 206(5), 584-595. doi:10.1164/rccm.202201-0033OC9.
Rusu, S., Verocq, C., Trepant, A.-L., Maris, C., De Nève, N., Blanchard, O., Van Campenhout, C., De Clercq, S., Rorive, S., Cotoi, O. S., Decaestecker, C., Salmon, I., & D'Haene, N. (2021). Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma. Molecular and clinical oncology, 15(6), 270. doi:10.3892/mco.2021.243210.
Mauri, F., Schepkens, C., Lapouge, G., Drogat, B., Song, Y., Pastushenko, I., Rorive, S., Blondeau, J., Golstein, S., Bareche, Y., Miglianico, M., Nkusi, E., Rozzi, M., Moers, V., Brisebarre, A., Raphael, M., Dubois, C., Durdu, B., Ribeiro, F., Sotiriou, C., Salmon, I., Vakili, J., & Blanpain, C. (2021). NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation. Nature Cancer, 2(11), 1152-1169. doi:10.1038/s43018-021-00287-511.
Thouvenin, J., Colinet, V., Barthelemy, P., Sideris, S., Van Eycken, M., Rorive, S., Sirtaine, N., Hamid, A., Roumeguere, T., & Chanza, N. M. (2021). 624P Prevalence and clinical impact of PTEN status in patients (pts) with de novo metastatic hormone sensitive prostate cancer (mHSPC). Annals of oncology, 32, S661. doi:10.1016/j.annonc.2021.08.113712.
Bogaert, B., Tulelli, B., Rodesch, M., Pregardien, C., Rorive, S., & Lingier, P. (2021). Urachal mucinous cystadenoma in infant: First case report in infant and review of literature. Journal of Pediatric Surgery Case Reports, 71, 101942. doi:10.1016/j.epsc.2021.101942